Biogen (BIIB) Q1 2017 Results - Earnings Call Transcript

4/26/17

Biogen, Inc. (NASDAQ:BIIB)

Q1 2017 Earnings Call

April 25, 2017 8:30 am ET

Executives

Matthew Calistri - Biogen, Inc.

Michel Vounatsos - Biogen, Inc.

Michael D. Ehlers, M.D., Ph.D. - Biogen, Inc.

Paul J. Clancy - Biogen, Inc.

Alfred W. Sandrock - Biogen, Inc.

Analysts

Eric Schmidt - Cowen & Co. LLC

Geoffrey C. Porges - Leerink Partners LLC

Geoff Meacham - Barclays Capital, Inc.

Umer Raffat - Evercore Group LLC

Ronny Gal - Sanford C. Bernstein Limited

Cory W. Kasimov - JPMorgan Securities LLC

Ying Huang - Bank of America Merrill Lynch

Joshua E. Schimmer - Piper Jaffray & Co.

Salim Syed - Mizuho Securities USA, Inc.

Alethia Young - Credit Suisse Securities (NYSE:USA) LLC

Terence Flynn - Goldman Sachs & Co.

Matthew K. Harrison - Morgan Stanley & Co. LLC

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.